Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria
AUTOR(ES)
Brown-Elliott, Barbara A.
FONTE
American Society for Microbiology
RESUMO
By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at ≤0.12 μg/ml and 90% of the Mycobacterium chelonae isolates at ≤4 μg/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=128789Documentos Relacionados
- Activities of Linezolid against Rapidly Growing Mycobacteria
- Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
- In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria.
- In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.
- Activities of Trovafloxacin, Gatifloxacin, Clinafloxacin, Sparfloxacin, Levofloxacin, and Ciprofloxacin against Penicillin-Resistant Streptococcus pneumoniae in an In Vitro Infection Model